These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 710023)

  • 21. Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.
    Keim HJ; Drayer JI; Thurston H; Laragh JH
    Arch Intern Med; 1976 Jun; 136(6):645-8. PubMed ID: 1275620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F; Braun B; Klaus D; Lemke R; Zehner J; Zöfel P
    Dtsch Med Wochenschr; 1975 Mar; 100(12):577-84. PubMed ID: 1168122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.
    Wenzl HH; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Dig Dis Sci; 1997 Jan; 42(1):119-28. PubMed ID: 9009126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of aldosterone in the sodium retention of patients with nephrotic syndrome.
    Shapiro MD; Hasbargen J; Hensen J; Schrier RW
    Am J Nephrol; 1990; 10(1):44-8. PubMed ID: 2188506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.
    Michaelis M; Hofmann PJ; Götz F; Bartel C; Kienitz T; Quinkler M
    Horm Metab Res; 2012 Apr; 44(4):291-5. PubMed ID: 22266825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension.
    Falch DK; Johansson R; Odegaard AE; Norman N
    Scand J Clin Lab Invest; 1979 Apr; 39(2):159-65. PubMed ID: 523964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans.
    Sawathiparnich P; Kumar S; Vaughan DE; Brown NJ
    J Clin Endocrinol Metab; 2002 Feb; 87(2):448-52. PubMed ID: 11836266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 32. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 33. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
    Parfrey PS; Markandu ND; Roulston JE; Jones BE; Jones JC; MacGregor GA
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):94-7. PubMed ID: 6789950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Med Welt; 1980 Aug; 31(31-32):1135-7. PubMed ID: 7421547
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of spironolactone treatment on the renin-aldosterone system during pregnancy.
    Lammintausta R; Erkkola R
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):294-8. PubMed ID: 489194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
    Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings: Acute and chronic effects of the aldosterone antagonist spironolactone and its main metabolite canrenone on plasma aldosterone concentration, plasma renin activity, serum electrolytes and on the excretion of aldosterone, fluid and electrolytes in rats.
    Erbler HC; Hilfenhaus M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R52. PubMed ID: 1143449
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C; Mallamaci F; Parlongo S
    J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.